iNOS Antibody (K13-A) | Novus Biologicals NBP1-33780-0.1ml product information

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

iNOS Antibody (K13-A)

catalog :

NBP1-33780-0.1ml

quantity :

0.1 ml

price :

509 USD

clonality :

monoclonal

host :

domestic rabbit

conjugate :

nonconjugated

clone name :

K13-A

reactivity :

human, mouse, rat

application :

western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section

more info or order :

Novus Biologicals product webpage

citations: 14

Reference
Li X, Ke Y, Hernandez A, Yu J, Bian L, Hall S, et al. Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis. Cancer Lett. 2023;570:216330 pubmed publisher
Sun A, Hu A, Lin J, Wang L, Xie C, Shi Y, et al. Involvement of iNOS-induced reactive enteric glia cells in gastrointestinal motility disorders of postoperative Ileus mice. J Chem Neuroanat. 2023;133:102312 pubmed publisher
Salm D, Horewicz V, Tanaka F, Ferreira J, de Oliveira B, Maio J, et al. Electrical Stimulation of the Auricular Branch Vagus Nerve Using Random and Alternating Frequencies Triggers a Rapid Onset and Pronounced Antihyperalgesia via Peripheral Annexin A1-Formyl Peptide Receptor 2/ALX Pathway in a Mouse Model of Persistent . Mol Neurobiol. 2023;60:2889-2909 pubmed publisher
Fernandes P, Galassi T, Horewicz V, Salgado A, Mack J, Baldan xe7 a H, et al. Immunoregulatory Effect of Preventive Supplementation of Omega-3 Fatty Acid in a Complex Regional Pain Syndrome Type I Model in Mice. Front Integr Neurosci. 2022;16:818692 pubmed publisher
Omura C, L xfc dtke D, Horewicz V, Fernandes P, Galassi T, Salgado A, et al. Decrease of IL-1β and TNF in the Spinal Cord Mediates Analgesia Produced by Ankle Joint Mobilization in Complete Freund Adjuvant-Induced Inflammation Mice Model. Front Physiol. 2021;12:816624 pubmed publisher
Chung A, Anand K, Anselme A, Chan A, Gupta N, Venta L, et al. A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer. Sci Transl Med. 2021;13:eabj5070 pubmed publisher
Anderson Baucum E, Piñeros A, Kulkarni A, Webb Robertson B, Maier B, Anderson R, et al. Deoxyhypusine synthase promotes a pro-inflammatory macrophage phenotype. Cell Metab. 2021;33:1883-1893.e7 pubmed publisher
de Brito R, Ludtke D, de Oliveira B, de Oliveira Galassi T, Fernandes P, Van Den Berge S, et al. Balneotherapy decreases mechanical hyperalgesia by reversing BDNF and NOS2 immunocontent in spinal cord of mice with neuropathic pain. J Neuroimmunol. 2020;348:577360 pubmed publisher
Lee M, Wang C, Jin S, Labrecque M, Beischlag T, Brockman M, et al. Expression of human inducible nitric oxide synthase in response to cytokines is regulated by hypoxia-inducible factor-1. Free Radic Biol Med. 2019;130:278-287 pubmed publisher
Yan J, Tie G, Wang S, Tutto A, DeMarco N, Khair L, et al. Diabetes impairs wound healing by Dnmt1-dependent dysregulation of hematopoietic stem cells differentiation towards macrophages. Nat Commun. 2018;9:33 pubmed publisher
Imamichi Y, Sekiguchi T, Kitano T, Kajitani T, Okada R, Inaoka Y, et al. Diethylstilbestrol administration inhibits theca cell androgen and granulosa cell estrogen production in immature rat ovary. Sci Rep. 2017;7:8374 pubmed publisher
Perelygina L, Plotkin S, Russo P, Hautala T, Bonilla F, Ochs H, et al. Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2016;138:1436-1439.e11 pubmed publisher
Granados Principal S, Liu Y, Guevara M, Blanco E, Choi D, Qian W, et al. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Res. 2015;17:25 pubmed publisher
Oh J, Lee H, Ko A, Ko J, Kim M, Wee W. Analysis of macrophage phenotype in rejected corneal allografts. Invest Ophthalmol Vis Sci. 2013;54:7779-84 pubmed publisher

product information

master code :

NBP1-33780

SKU :

NBP1-33780-0.1ml

product name :

iNOS Antibody (K13-A)

unit size :

0.1 ml

description :

The iNOS Antibody (K13-A) from Novus is a rabbit monoclonal antibody to iNOS. This antibody reacts with human,mouse,porcine,rat. The iNOS Antibody (K13-A) has been validated for the following applications: IF/IHC,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Knockdown Validated,Immunocytochemistry/ Immunofluorescence.

target :

iNOS

category :

Primary Antibodies

buffer :

20mM Tris-HCl (pH 8.0) and 20mg/ml BSA

clonality :

Monoclonal

clone :

K13-A

conjugate :

Unconjugated

host :

Rabbit

immunogen :

Peptide derived from human iNOS sequence. Antibody recognizes the epitope between Ser1118 - Gly1129.

isotype :

IgG

purity :

Immunogen affinity purified

species :

Human,Mouse,Porcine,Rat

gene symbol :

NOS2

accessionNumbers :

P35228

applications :

IF/IHC,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Knockdown Validated,Immunocytochemistry/ Immunofluorescence

USD :

509 USD

alt names :

EC 1.14.13.39, Hepatocyte NOS, HEP-NOS, Inducible NO synthase, Inducible NOS, INOS, nitric oxide synthase 2, inducible, nitric oxide synthase 2A (inducible, hepatocytes), nitric oxide synthase, inducible, nitric oxide synthase, macrophage, NOS, NOS type II, NOS2A, Peptidyl-cysteine S-nitrosylase NOS2

storage :

Store at 4C. Do not freeze.

more info or order :

Novus Biologicals product webpage